earnings
AC
NASDAQ · ACET
Adicet Bio, Inc.
Healthcare · Biotechnology
$3.05
Down-$0.06 (-1.97%)
Updated Nov 9, 2026, 10:10 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 69.44M
- P/E ratio
- -0.36
- Dividend yield
- 0.00%
- 52-week range
- $2.87 – $9.97
- Volume
- 254.06K
- Avg. volume
- 192.48K
Price performance · ACET
ACET price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
ACET closed at $3.05 after 20 trading sessions, down 44.85% for the selected period.
- Last close
- $3.05
- Period change
- -44.85%
- Period low
- $2.92
- Period high
- $5.53
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $2.89 | $3.1442 | $2.89 | $3.05 | 254.06K |
| Nov 5, 2026 | $3.03 | $3.05 | $2.87 | $2.92 | 420.44K |
| Nov 4, 2026 | $3.26 | $3.31 | $2.99 | $3.10 | 292.35K |
| Nov 3, 2026 | $3.20 | $3.34 | $3.13 | $3.17 | 175.83K |
| Nov 2, 2026 | $3.42 | $3.465 | $3.18 | $3.20 | 250.31K |
| Oct 30, 2026 | $3.68 | $3.74 | $3.32 | $3.42 | 242.49K |
| Oct 29, 2026 | $3.83 | $3.86 | $3.56 | $3.58 | 176.21K |
| Oct 28, 2026 | $3.80 | $3.86 | $3.71 | $3.81 | 178.82K |
| Oct 27, 2026 | $3.94 | $3.97 | $3.77 | $3.81 | 178.17K |
| Oct 26, 2026 | $4.00 | $4.055 | $3.81 | $3.94 | 162.81K |
| Oct 23, 2026 | $4.22 | $4.29 | $3.96 | $3.99 | 162.97K |
| Oct 22, 2026 | $4.50 | $4.72 | $4.21 | $4.28 | 157.16K |
| Oct 21, 2026 | $4.52 | $4.7356 | $4.44 | $4.49 | 182K |
| Oct 20, 2026 | $4.53 | $4.715 | $4.49 | $4.52 | 126.53K |
| Oct 19, 2026 | $4.57 | $4.745 | $4.39 | $4.53 | 230.32K |
| Oct 16, 2026 | $5.14 | $5.14 | $4.57 | $4.57 | 188.79K |
| Oct 15, 2026 | $4.90 | $5.17 | $4.88 | $5.14 | 155.1K |
| Oct 14, 2026 | $5.10 | $5.27 | $4.8001 | $4.89 | 357.87K |
| Oct 13, 2026 | $5.53 | $5.53 | $5.10 | $5.11 | 326.9K |
| Oct 12, 2026 | $5.55 | $5.84 | $5.17 | $5.53 | 145.88K |
Latest ACET news
The latest Smart Investors Daily articles mentioning ACET.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

